34 citations,
March 2001 in “Cleveland Clinic Journal of Medicine” Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.
34 citations,
August 2002 in “British Journal of Dermatology” ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.
29 citations,
June 2013 in “Journal of the Saudi Society of Dermatology & Dermatologic Surgery” Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.
29 citations,
August 2008 in “Current Opinion in Pediatrics” Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.
28 citations,
January 2016 in “Dermatology” Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.
28 citations,
May 1998 in “Journal of the American Academy of Dermatology” Scalp inflammation can cause multiple hairs to grow from one follicle.
24 citations,
October 2012 in “Journal of Ginseng Research” Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.
22 citations,
February 2002 in “Clinics in Geriatric Medicine” Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.
16 citations,
May 2013 in “Australasian Journal of Dermatology” Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.
15 citations,
May 2017 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.
14 citations,
January 2015 in “Annals of dermatology/Annals of Dermatology” Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.
10 citations,
February 2011 in “Journal der Deutschen Dermatologischen Gesellschaft” The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.
9 citations,
July 2010 in “Pediatric dermatology” Corticosteroids worked better than anthralin cream for hair regrowth.
8 citations,
January 2020 in “Plastic and Aesthetic Nursing” The article concludes that different types of hair loss require specific treatments and psychological support is important.
7 citations,
September 2015 in “Actas Dermo-Sifiliográficas” Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.
7 citations,
January 2016 in “Dermatology online journal” Persistent pulling on hair can cause permanent hair loss.
6 citations,
September 1998 in “Dermatologic surgery” Hair transplant surgeons did not agree on which drugs to use except for local anesthetics, and there was no strong evidence supporting their drug choices.
6 citations,
August 1991 in “Pediatric Clinics of North America” The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.
Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.
1 citations,
July 1976 in “Archives of Dermatology” Some women experienced hair loss after stopping chorionic gonadotropin injections and a low-calorie diet.
1 citations,
May 2022 in “Journal of Drugs in Dermatology” Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.
1 citations,
January 2022 in “Clinical Cases in Dermatology” A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.
September 2024 in “PubMed” Hair loss can be treated based on its type and cause, improving quality of life.
Anifrolumab treatment for systemic lupus erythematosus (SLE) patients in Denmark significantly improved patient-reported quality of life and decreased disease activity and corticosteroid use. The study involved qualitative in-depth interviews with 14 patients and electronic medical record data from 16 patients. Common symptoms like fatigue, joint pain, and hair loss improved with treatment. Patients reported enhancements in daily activities, social life, and emotional well-being, although some impacts remained. The findings highlight the treatment's positive effects on both subjective experiences and objective health parameters.
The study on Anifrolumab treatment for systemic lupus erythematosus (SLE) patients revealed significant improvements in quality of life and a decrease in systemic corticosteroid use. Conducted through qualitative interviews with 14 patients and electronic medical record data from 16 patients, the research highlighted a reduction in bothersome symptoms such as fatigue, joint pain, and hair loss. Patients reported enhanced daily life activities, social interactions, and emotional well-being post-treatment. Additionally, clinical data showed decreased disease activity and improved laboratory results, supporting the subjective reports of symptom alleviation. These findings underscore the efficacy of Anifrolumab in managing SLE.
March 2024 in “Poster presentations” The study on Anifrolumab treatment for systemic lupus erythematosus (SLE) involved qualitative interviews with 14 patients and electronic medical record data from 16 patients. It found that Anifrolumab improved symptoms such as fatigue, joint pain, sun sensitivity, skin rashes, and hair loss, although these symptoms were still present. Patients reported enhancements in daily activities, emotional well-being, social life, physical activity, concentration, work, and relationships. Additionally, there was a reduction in disease activity and corticosteroid use. The study highlights the positive impact of Anifrolumab on both subjective experiences and clinical outcomes for SLE patients.
May 2023 in “Journal of Investigative Dermatology” Some patients who had a severe drug reaction developed long-term hair loss.
Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.
August 2022 in “The journal of investigative dermatology/Journal of investigative dermatology” Early diagnosis and treatment of hair loss in hijab-wearing women are crucial to prevent permanent damage and improve quality of life.
January 2022 in “Journal of the Egyptian Women's Dermatologic Society (Print)” Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.